In this video, Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN, briefly discusses the potential role of bispecific antibodies in Waldenström’s macroglobulinemia (WM), highlighting the limited data in this space, and further evaluates the activity of odronextamab in WM and other lymphomas. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
The role of bispecifics in WM
Теги
Speaker: Stephen AnsellInstitution: Mayo ClinicEvent: IWWM-11 2022Format: InterviewSubject: LymphomaSubject: Non-Hodgkin LymphomaSubject: Rare DiseasesSubject: Waldenström’s macroglobulinemiaField: Immuno-oncologyField: TreatmentMedicines: OdronextamabMedicines: Antibodiesbispecific antibodiesCD3CD20Subject: Marginal zone lymphomaSubject: Follicular lymphomaField: Perspectives
![Полный курс по ОСОЗНАННЫМ СНАМ с нуля до профи [72 лекции]](https://i.ytimg.com/vi/EgxnBPMffJg/mqdefault.jpg)
![Ich zieh meiner dunklen Straße [German Fahrtenlied][+English translation]](https://i.ytimg.com/vi/k-xsaHfrQ3w/mqdefault.jpg)
